Vitenskapelig litteraturgjennomgang

• Håkon Reikvam; Kimberley Joanne Hatfield; Hanne Kristin Fredly et al. (2012). The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation. (ekstern lenke)
• Øystein Bruserud; Håkon Reikvam; Annette Brenner (2022). Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia. (ekstern lenke)
• Håkon Reikvam; Ramon V. Tiu (2012). Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera. (ekstern lenke)
• Sushma Bartaula-Brevik; Marte Karen Brattås; Tor Henrik Anderson Tvedt et al. (2018). Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia. (ekstern lenke)
• Hanne Wiese-Hansen; Friedemann Leh; Anette Lodvir Hemsing et al. (2021). Immunoglobulin-storing histiocytosis: A case based systemic review. (ekstern lenke)
• Øyvind Bruserud; Knut Anders Mosevoll; Einar Klæboe Kristoffersen et al. (2021). Trombocytopeni hos kritisk syke pasienter. (ekstern lenke)
• Håkon Reikvam; Tuyen Hoang; Øystein Bruserud (2015). Emerging therapeutic targets in human acute myeloid leukemia (part 2) – bromodomain inhibition should be considered as a possible strategy for various patient subsets. (ekstern lenke)
• Sigrun Margrethe Hjelle; Rakel Brendsdal Forthun; Ingvild Haaland et al. (2010). Clinical proteomics of myeloid leukemia. (ekstern lenke)
• Øystein Wendelbo; Tor Hervig; Oddbjørn Haugen et al. (2017). Microcirculation and red cell transfusion in patients with sepsis. (ekstern lenke)
• Knut Anders Mosevoll; Silje Johansen; Øystein Wendelbo et al. (2018). Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis. (ekstern lenke)
• Håkon Reikvam; Galina Tsykunova; Miriam Sandnes et al. (2025). Infectious complications and the utility of serum and cellular markers of infections in the setting of allogeneic hematopoietic stem cell transplantation. (ekstern lenke)
• Håkon Reikvam; Hanne Kristin Fredly; Astrid Marta Olsnes Kittang et al. (2013). The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine-the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation. (ekstern lenke)
• Anette Lodvir Hemsing; Randi Hovland; Galina Tsykunova et al. (2019). Trisomy 8 in acute myeloid leukemia. (ekstern lenke)
• Annette Brenner; Håkon Reikvam; Antonio Lavecchia et al. (2014). Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid Leukemia - The possibility to target several kinases through inhibition of the various CDC25 isoforms. (ekstern lenke)
• Daniel Limi Cacic; Tor Hervig; Håkon Reikvam (2023). Platelets for advanced drug delivery in cancer. (ekstern lenke)
• Øystein Bruserud; Elise Aasebø; Maria Hernandez-Valladares et al. (2017). Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies. (ekstern lenke)
• Jenny Gretland; Sigrun Sjømæling; Knut Anders Mosevoll et al. (2025). Timing of antibiotic initiation in sepsis and neutropenic fever. (ekstern lenke)
• Øystein Bruserud; Håkon Reikvam (2025). NUP214 in Acute Myeloid Leukemia. (ekstern lenke)
• Håkon Reikvam; Unni Sandaker Blom; Einar Klæboe Kristoffersen et al. (2009). Granulocyttransfusjon. (ekstern lenke)
• Øystein Bruserud; Knut Anders Mosevoll; Øyvind Bruserud et al. (2023). The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients. (ekstern lenke)
• Øystein Bruserud; Frode Selheim; Maria del Carmen Hernandez Valladares et al. (2024). Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies. (ekstern lenke)
• Øyvind Bruserud; Knut Anders Mosevoll; Einar Klæboe Kristoffersen et al. (2021). Thrombocytopaenia in the critically ill. (ekstern lenke)
• Øystein Bruserud; Håkon Reikvam; Astrid Marta Olsnes Kittang et al. (2012). High-dose etoposide in allogeneic stem cell transplantation. (ekstern lenke)
• Øystein Bruserud; Håkon Reikvam (2023). Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia. (ekstern lenke)
• Galina Tsykunova; Håkon Reikvam; Aymen B Ahmed et al. (2012). Targeting of polo-like kinases and their cross talk with Aurora kinases - possible therapeutic strategies in human acute myeloid leukemia?. (ekstern lenke)
• Ida Sofie Grønningsæter; Galina Tsykunova; Kyrre Flattun Lilleeng et al. (2017). Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment. (ekstern lenke)
• Silje Johansen; Annette Brenner; Sushma Bartaula-Brevik et al. (2018). The possible importance of β3 integrins for leukemogenesis and chemoresistance in acute myeloid leukemia. (ekstern lenke)
• Miriam Sandnes; Rune Johan Ulvik; Marta Vorland et al. (2021). Hyperferritinemia—a clinical overview. (ekstern lenke)
• Camilla I Stapnes; Bjørn Tore Gjertsen; Håkon Reikvam et al. (2009). Targeted therapy in acute myeloid leukaemia: current status and future directions. (ekstern lenke)
• Håkon Reikvam; Annette Brenner; Ina Nepstad et al. (2014). Heat shock protein 70 - the next chaperone to target in the treatment of human acute myelogenous leukemia?. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Astrid Marta Olsnes Kittang et al. (2011). Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications. (ekstern lenke)
• Øystein Bruserud; Frode Selheim; Maria del Carmen Hernandez Valladares et al. (2025). XPO1/Exportin-1 in Acute Myelogenous Leukemia; Biology and Therapeutic Targeting. (ekstern lenke)
• Ina Nepstad; Kimberley Joanne Hatfield; Ida Sofie Grønningsæter et al. (2020). The PI3K-AKT-MTOR signaling pathway in human acute myeloid leukemia (AML) cells. (ekstern lenke)
• Håkon Reikvam; Rakel Brendsdal Forthun; Annette Brenner et al. (2014). Heat shock protein 90 – a potential target in the treatment of human acute myelogenous leukemia. (ekstern lenke)
• Øystein Bruserud; Anh Khoi Vo; Håkon Reikvam (2022). Hematopoiesis, Inflammation and Aging—The Biological Background and Clinical Impact of Anemia and Increased C‐Reactive Protein Levels on Elderly Individuals. (ekstern lenke)
• Håkon Reikvam; Randi Hovland; Øystein Bruserud (2014). Akutt promyelocyttleukemi. (ekstern lenke)
• Elisabeth Ersvær; Kimberley Joanne Hatfield; Håkon Reikvam et al. (2011). Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies. (ekstern lenke)
• Katarina Mariann Jørgensen; Sigrun Margrethe Hjelle; Ola Kristoffer Øye et al. (2011). Untangling the intracellular signalling network in cancer - a strategy for data integration in acute myeloid leukemia. (ekstern lenke)
• Reidar Kvåle; Nessar Ahmad Azrakhsh; Kristin Greve Isdahl Mohn et al. (2020). COVID-19 and venous thromboembolism - prophylaxis and treatment. (ekstern lenke)
• Kimberley Joanne Hatfield; Håkon Reikvam; Øystein Bruserud (2010). The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia. (ekstern lenke)
• Håkon Reikvam; Michelle Victoria Hauge; Annette Brenner et al. (2015). Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication. (ekstern lenke)
• Trym Fauchald; Bjørn Blomberg; Håkon Reikvam (2023). Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: A Review of Current Literature. (ekstern lenke)
• Marte Karen Brattås; Håkon Reikvam; Tor Henrik Anderson Tvedt et al. (2019). Precision medicine for TP53-mutated acute myeloid leukemia. (ekstern lenke)
• Bent Are Hansen; Øystein Wendelbo; Øystein Bruserud et al. (2020). Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment. (ekstern lenke)
• Tor Henrik Anderson Tvedt; Anh Khoi Vo; Øystein Bruserud et al. (2021). Cytokine release syndrome in the immunotherapy of hematological malignancies: The biology behind and possible clinical consequences. (ekstern lenke)
• Kristin Ølfarnes Storhaug; Dag Harald Skutlaberg; Bent Are Hansen et al. (2021). Carbapenem‐resistant enterobacteriaceae—implications for treating acute leukemias, a subgroup of hematological malignancies. (ekstern lenke)
• Astrid Marta Olsnes Kittang; Kimberley Joanne Hatfield; Kristoffer Evebø Sand et al. (2010). The Chemokine Network in Acute Myelogenous Leukemia: Molecular Mechanisms Involved in Leukemogenesis and Therapeutic Implications. (ekstern lenke)
• Håkon Reikvam; Vo Anh (2020). GRAFT MOT VERT SJUKDOM. (ekstern lenke)
• Øystein Bruserud; Ina Nepstad; Michelle Victoria Hauge et al. (2015). STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Miriam Sandnes et al. (2024). Future biomarkers for acute graft-versus-host disease: potential roles of nucleic acids, metabolites, and immune cell markers. (ekstern lenke)
• Øystein Bruserud; Tor Henrik Anderson Tvedt; Petter Quist-Paulsen et al. (2014). Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: Immunological mechanisms and the results from clinical studies. (ekstern lenke)
• Andrea Solberg; Håkon Reikvam (2023). Iron Status and Physical Performance in Athletes. (ekstern lenke)
• Linn Rolsdorph; Knut Anders Mosevoll; Lars Helgeland et al. (2022). Concomitant Hemophagocytic Lymphohistiocytosis and Cytomegalovirus Disease: A Case Based Systemic Review. (ekstern lenke)
• Øystein Bruserud; Galina Tsykunova; Maria Hernandez-Valladares et al. (2021). Therapeutic use of valproic acid and all-trans retinoic acid in acute myeloid leukemia—literature review and discussion of possible use in relapse after allogeneic stem cell transplantation. (ekstern lenke)
• Håkon Reikvam; Elisabeth Ersvær; Øystein Bruserud (2009). Heat shock protein 90-a potential target in the treatment of human acute myelogenous leukemia. (ekstern lenke)

Vitenskapelig artikkel

• Håkon Reikvam; Annette Brenner; Karen Marie Hagen et al. (2015). The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells. (ekstern lenke)
• Silje Johansen; Bjørn Blomberg; Anh Khoi Vo et al. (2022). Weight gain during treatment course of allogenic hematopoietic stem cell transplantation in patients with hematological malignancies affects treatment outcome. (ekstern lenke)
• Lise Mayrin Økland Thunestvedt; Lars Helgeland; Ingeborg Margrethe Bachmann et al. (2022). Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis. (ekstern lenke)
• Håkon Reikvam (2020). Inhibition of NF-κB signaling alters acute myelogenous leukemia cell transcriptomics. (ekstern lenke)
• Seyed Mohammad Lellahi; Waqas Azeem; Yaping Hua et al. (2023). GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2. (ekstern lenke)
• Håkon Reikvam; Anne Margrete Øyan; Karl-Henning Kalland et al. (2013). Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients. (ekstern lenke)
• Håkon Reikvam; Ida Sofie Grønningsæter; Knut Anders Mosevoll et al. (2018). Patients with treatment-requiring chronic graft versus host disease after allogeneic stem cell transplantation have altered metabolic profiles due to the disease and immunosuppressive therapy: Potential implication for biomarkers. (ekstern lenke)
• Håkon Reikvam; Randi Hovland; Rakel Brendsdal Forthun et al. (2017). Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells. (ekstern lenke)
• Håkon Reikvam; Astrid Marta Olsnes; Bjørn Tore Gjertsen et al. (2009). Nuclear Factor-kappaB Signaling: A Contributor in Leukemogenesis and a Target for Pharmacological Intervention in Human Acute Myelogenous Leukemia. (ekstern lenke)
• Håkon Reikvam; Ina Nepstad; Øystein Bruserud et al. (2013). Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells. (ekstern lenke)
• Anette Lodvir Hemsing; Håkon Reikvam (2019). Mondor's disease after extensive training with Nordic walking. (ekstern lenke)
• Annette Brenner; Håkon Reikvam; Øystein Bruserud (2016). A subset of patients with acute myeloid leukemia has leukemia cells characterized by chemokine responsiveness and altered expression of transcriptional as well as angiogenic regulators. (ekstern lenke)
• Håkon Reikvam; Ina Nepstad; Andre Sulen et al. (2013). Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors. (ekstern lenke)
• Ingvild Haaland; Sigrun Margrethe Hjelle; Håkon Reikvam et al. (2021). p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy. (ekstern lenke)
• Ole Farestvedt Raaheim; Dag Farestvedt Raaheim; Håkon Reikvam et al. (2022). Eksamensformer i de norske medisinstudiene. (ekstern lenke)
• Håkon Reikvam; Øystein Bruserud; Kimberley Joanne Hatfield (2023). Pretransplant systemic metabolic profiles in allogeneic hematopoietic stem cell transplant recipients - identification of patient subsets with increased transplant-related mortality. (ekstern lenke)
• Marte Karen Brattås; Håkon Reikvam; Tor Henrik Anderson Tvedt et al. (2019). Dasatinib is an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. (ekstern lenke)
• Knut Anders Mosevoll; Steinar Skrede; DAGFINN LUNDE MARKUSSEN et al. (2018). Inflammatory mediator profiles differ in sepsis patients with and without bacteremia. (ekstern lenke)
• Håkon Reikvam; Susanne Marschner; Torunn Oveland Apelseth et al. (2010). The Mirasol (R) Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution. (ekstern lenke)
• Ina Nepstad; Kimberley Joanne Hatfield; Ida Sofie Grønningsæter et al. (2019). Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells.. (ekstern lenke)
• Håkon Reikvam; Anh Khoi Vo; Silje Johansen et al. (2022). MicroRNA serum profiles and chronic graft-versus-host disease. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Philippe Lassalle et al. (2010). Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release. (ekstern lenke)
• Marte Karen Brattås; Kyrre Flattun Lilleeng; Randi Hovland et al. (2018). Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis. (ekstern lenke)
• Magnus Gramstad Rolfsnes; Guido Smits; Silje Johansen et al. (2026). Endothelial activation and stress index (EASIX) score is a stronger predictor of survival after allogeneic hematopoietic stem cell transplantation than acute-phase biomarkers. (ekstern lenke)
• Ane Sofie Tønne Nesse; Hilde Kollsete Gjelberg; Miriam Sandnes et al. (2025). Non-MPL-W515K/L mutations in myeloproliferative neoplasms: Insights from two case reports and a review of the literature. (ekstern lenke)
• Ingeborg Nerbø Reiten; Reidun Æsøy; Jan-Lukas Førde et al. (2025). Phenazine 5,10-dioxide analogues as potential therapeutics in AML: Efficacy on patient-derived blasts, in zebrafish larvae xenografts and synergy with venetoclax. (ekstern lenke)
• Håkon Reikvam; Knut Anders Mosevoll; Guro Kristin Melve et al. (2012). The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of posttransplantation complications. (ekstern lenke)
• Knut Anders Mosevoll; Roald Lindås; Tor Henrik Anderson Tvedt et al. (2015). Altered plasma levels of cytokines, soluble adhesion molecules and matrix metalloproteases in venous thrombosis. (ekstern lenke)
• Silje Johansen; Lars Helgeland; Nils Vetti et al. (2019). En mann i 70-årene med ryggsmerter, mageplager og utslett. (ekstern lenke)
• Marte Karen Brattås; Anette Lodvir Hemsing; Kristin Paulsen Rye et al. (2022). Heterogeneity of patient-derived acute myeloid leukemia cells subjected to SYK in vitro inhibition. (ekstern lenke)
• Anita Ryningen; Håkon Reikvam; Ina Nepstad et al. (2012). Inhibition of Mammalian target of rapamycin in human acute myeloid leukemia cells has diverse effects that depend on the environmental in vitro stress. (ekstern lenke)
• Tor Henrik Anderson Tvedt; Håkon Reikvam; Øystein Bruserud (2016). Nutrition in allogeneic stem cell transplantion - Clinical guidelines and immunobiological aspects. (ekstern lenke)
• Øystein Bruserud; Håkon Reikvam; Hanne Kristin Fredly et al. (2015). Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation. (ekstern lenke)
• Daniel Cacic; Håkon Reikvam; Oddmund Nordgård et al. (2021). Platelet microparticles protect acute myelogenous leukemia cells against daunorubicin-induced apoptosis. (ekstern lenke)
• Håkon Reikvam; Ida Sofie Grønningsæter; Aymen B Ahmed et al. (2015). Metabolic serum profiles for patients receiving allogeneic stem cell transplantation: the pretransplant profile differs for patients with and without posttransplant capillary leak syndrome. (ekstern lenke)
• Helene Daae-Qvale Holmemo; Håkon Reikvam (2022). Leukemia cutis. (ekstern lenke)
• Bent Are Hansen; Svein Amundsen; Håkon Reikvam et al. (2017). Non-curative surgery for aortoenteric fistula. (ekstern lenke)
• Andreas Benneche; Miriam Sandnes; Åsne Bakke et al. (2020). Hyperferritinemi-katarakt-syndrom. (ekstern lenke)
• Roald Lindås; Tor Henrik Anderson Tvedt; Kimberley Joanne Hatfield et al. (2014). Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation.. (ekstern lenke)
• Ingrid Anna Teigen; Anna Kristine M. Sæle; Håkon Reikvam (2020). A Patient With Maculopapular Rash and Lichenoid Skin Damage Caused by Ponatinib. (ekstern lenke)
• Trung Quang Ha; Vibeke Andresen; Bjarte Skoe Erikstein et al. (2024). Preclinical activity of resazurin in acute myeloid leukaemia. (ekstern lenke)
• Linn Trovik; Miriam Sandnes; Bjørn Blomberg et al. (2020). Hemophagocytic lymphohistiocytosis and miliary tuberculosis in a previously healthy individual: a case report. (ekstern lenke)
• Henry Røyset Almedal; Marta Vorland; Aasne Karine Aarsand et al. (2016). Myeloproliferative neoplasiar og JAK2-mutasjonar :. (ekstern lenke)
• Håkon Reikvam; Jørn Skavland; Stein-Erik Gullaksen et al. (2018). Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation. (ekstern lenke)
• Henriette Kronstad Helland; Thorkild Tylleskär; Monika Kvernenes et al. (2022). An Abrupt Transition to Digital Teaching—Norwegian Medical Students and Their Experiences of Learning Output during the Initial Phase of the COVID-19 Lockdown. (ekstern lenke)
• Håkon Reikvam; Leo van de Watering; Chris V. Prowse et al. (2011). Evaluation of noninvasive methods for the estimation of haemoglobin content in red blood cell concentrates. (ekstern lenke)
• Marta Brunetti; Hilde Kollsete Gjelberg; Håkon Reikvam et al. (2025). Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Anne Margrete Øyan et al. (2009). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors; release profile and pharmacological modulaion. (ekstern lenke)
• Håkon Reikvam; Jakob Dalgaard; Silje Johansen et al. (2019). Behandling av akutt myelogen leukemi hos eldre. (ekstern lenke)
• Miriam Sandnes; Marta Vorland; Rune J. Ulvik et al. (2021). Hfe genotype, ferritin levels and transferrin saturation in patients with suspected hereditary hemochromatosis. (ekstern lenke)
• Alexander Dåtland Kvinge; Tobias Kvammen; Hrvoje Miletic et al. (2022). Musculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature. (ekstern lenke)
• Øyvind Bruserud; Øystein Wendelbo; Nils Vetti et al. (2020). Critical upper airway obstruction as the first symptom of acute myeloid leukemia - An anesthesiologic reminder. (ekstern lenke)
• Øystein Wendelbo; Elin Netland Opheim; Turid Helen Felli Lunde et al. (2017). A prospective observational study on effects of fever on red cell transfusion outcome. (ekstern lenke)
• Håkon Reikvam; Jerome Tamburini; Silje Skrede et al. (2014). Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect. (ekstern lenke)
• Marte Karen Brattås; Håkon Reikvam (2017). Ringsideroblaster. (ekstern lenke)
• Anette Lodvir Hemsing; Kristin Paulsen Rye; Kimberley Joanne Hatfield et al. (2022). NPM1-mutated patient-derived AML cells are more vulnerable to rac1 inhibition. (ekstern lenke)
• Kimberley Joanne Hatfield; Håkon Reikvam; Øystein Bruserud (2014). Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells. (ekstern lenke)
• Annette Brenner; Håkon Reikvam; Kristin Paulsen Rye et al. (2017). CDC25 inhibition in acute myeloid leukemia - A study of patient heterogeneity and the effects of different inhibitors. (ekstern lenke)
• Kimberley Joanne Hatfield; Lasse Evensen; Håkon Reikvam et al. (2012). Soluble mediators released by acute myeloid leukemia cells increase capillary-like networks. (ekstern lenke)
• Knut Anders Mosevoll; Cigdem Ahaein Akkøk; Tor Hervig et al. (2013). Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Anne Margrete Øyan et al. (2010). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. (ekstern lenke)
• Elise Aasebø; Annette Brenner; Maria Hernandez-Valladares et al. (2021). Proteomic Characterization of Spontaneous Stress-Induced In Vitro Apoptosis of Human Acute Myeloid Leukemia Cells; Focus on Patient Heterogeneity and Endoplasmic Reticulum Stress. (ekstern lenke)
• Elisabeth Ersvær; Annette Brenner; Kristin Vetås et al. (2015). Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid. (ekstern lenke)
• Håkon Reikvam; Aymen B Ahmed (2015). Plasmaceller med inklusjonar. (ekstern lenke)
• Håkon Reikvam; Elise Aasebø; Annette Brenner et al. (2019). High constitutive cytokine release by primary human acute myeloid leukemia cells is associated with a specific intercellular communication phenotype. (ekstern lenke)
• Guro Kristin Melve; Elisabeth Ersvær; Kristin Paulsen Rye et al. (2018). The healthy donor profile of immunoregulatory soluble mediators is altered by stem cell mobilization and apheresis. (ekstern lenke)
• Gülen Arslan Lied; Jian Chen; Håkon Reikvam (2013). Forskningsveiledning - en av de essensielle faktorene på «veien til doktorgrad». (ekstern lenke)
• Mikael Thomassen Neset; Roy Miodini Nilsen; Kristian Løvås et al. (2025). Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease. (ekstern lenke)
• Øystein Wendelbo; Elin Netland Opheim; Tor Hervig et al. (2018). Cytokine profiling and post-transfusion haemoglobin increment in patients with haematological diseases. (ekstern lenke)
• Øystein Bruserud; Knut Liseth; Siren Stamnesfet et al. (2013). Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. (ekstern lenke)
• Håkon Reikvam; Chris V. Prowse; Huw Roddie et al. (2010). A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusion. (ekstern lenke)
• Knut Anders Mosevoll; Roald Lindås; Øystein Wendelbo et al. (2014). Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis.. (ekstern lenke)
• Kimberley Joanne Hatfield; Øystein Bruserud; Håkon Reikvam (2022). Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients. (ekstern lenke)
• Anette Lodvir Hemsing; Jan-Lukas Førde; Håkon Reikvam et al. (2024). The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae. (ekstern lenke)
• Håkon Reikvam (2023). Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia. (ekstern lenke)
• Tor Henrik Anderson Tvedt; Stein Atle Lie; Håkon Reikvam et al. (2016). Pretransplant levels of CRP and interleukin-6 family cytokines; effects on outcome after allogeneic stem cell transplantation. (ekstern lenke)
• Håkon Reikvam; Egil Steien; Bjørn Hauge et al. (2009). Thrombelastography. (ekstern lenke)
• Marte Karen Brattås; Franziska Stilla Maria Görtler; Silje Johansen et al. (2025). Gene Expression Profiling in Acute Myeloid Leukemia Patient Subgroups With High and Low Sensitivity Toward SYK Inhibitors. (ekstern lenke)
• Ina Nepstad; Kimberley Joanne Hatfield; Elise Aasebø et al. (2018). Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic and transcriptomic comparison. (ekstern lenke)
• Knut Anders Mosevoll; Bent-Are Hansen; Ingunn Margareetta Gundersen et al. (2023). Systemic metabolomic profiles in adult patients with bacterial sepsis: Characterization of patient heterogeneity at the time of diagnosis. (ekstern lenke)
• Susanne Lilleskare; Marta Vorland; Anh Khoi Vo et al. (2022). Frequency of JAK2V617F, MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasms. (ekstern lenke)
• Håkon Reikvam; Tor Henrik Anderson Tvedt; Silje Johansen et al. (2020). Surgical Treatment of Severe Bowel Obstruction as a Rare Complication Following Allogenic Hematopoietic Stem Cell Transplantation. (ekstern lenke)
• Marte Karen Brattås; Håkon Reikvam; Tor Henrik Anderson Tvedt et al. (2019). Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. (ekstern lenke)
• Vibeke Andresen; Bjarte Skoe Erikstein; Herschel Mukherjee et al. (2016). Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. (ekstern lenke)
• Ina Nepstad; Kimberley Joanne Hatfield; Tor Henrik Anderson Tvedt et al. (2018). Clonal heterogeneity reflected by pi3k-akt-mtor signaling in human acute myeloid leukemia cells and its association with adverse prognosis. (ekstern lenke)
• Miriam Sandnes; Håkon Reikvam (2024). Hepcidin as a therapeutic target in iron overload. (ekstern lenke)
• Øystein Sefland; Stein-Erik Gullaksen; Maria Omsland et al. (2024). Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease. (ekstern lenke)
• Sissel Dyrstad; Kimberley Joanne Hatfield; Endre Stigen et al. (2025). Mapping of Functional Metabolic Phenotypes in Acute Myeloid Leukemia. (ekstern lenke)
• Miriam Sandnes; Håkon Reikvam (2022). Når blodet flyter langsomt. (ekstern lenke)
• Silje Johansen; Jostein Kråkenes; Christian Alexander Vedeler et al. (2022). Limbic encephalitis following allogeneic hematopoietic stem cell transplantation. (ekstern lenke)
• Ingvild Haaland; Jill Anette Opsahl; Frode Berven et al. (2014). Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. (ekstern lenke)
• Tor Henrik Andersson Tvedt; Christian Qvigstad; Katerina Nezvalova-Henriksen et al. (2025). Three-Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients. (ekstern lenke)
• Frode Selheim; Elise Aasebø; Håkon Reikvam et al. (2025). Proteomic Comparison of Acute Myeloid Leukemia Cells and Normal CD34⁺Bone Marrow Cells: Studies of Leukemia Cell Differentiation and Regulation of Iron Metabolism/Ferroptosis. (ekstern lenke)
• Øystein Bruserud; Tor Henrik Anderson Tvedt; Aymen B Ahmed et al. (2021). Spontaneous Splenic Artery Rupture as the First Symptom of Systemic Amyloidosis. (ekstern lenke)
• Håkon Reikvam; Anita Ryningen; Lars Rune Sæterdal et al. (2015). Connexin expression in human acute myeloid leukemia cells: Identification of patient subsets based on protein and global gene expression profiles.. (ekstern lenke)
• Silje Johansen; Ingvild Jenssen Lægreid; Siw Leiknes Ernstsen et al. (2021). Thrombosis and thrombocytopenia after HPV vaccination. (ekstern lenke)
• Peter Ferkis Steinfeld; Thomas Knoop; Linn Trovik et al. (2021). Kidney failure and abdominal discomfort as initial signs of extramedullary acute myelogenous Leukemia. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Øystein Wendelbo et al. (2022). Endocan in Acute Leukemia: Current Knowledge and Future Perspectives. (ekstern lenke)
• Ida Sofie Grønningsæter; Håkon Reikvam; Elise Aasebø et al. (2021). Effects of the autophagy‐inhibiting agent chloroquine on acute myeloid leukemia cells; characterization of patient heterogeneity. (ekstern lenke)
• Ida Sofie Grønningsæter; Håkon Reikvam; Elise Aasebø et al. (2020). Targeting cellular metabolism in acute myeloid leukemia and the role of patient heterogeneity. (ekstern lenke)
• Anne-Grete Reikvam; Simon Steinar Hustad; Håkon Reikvam et al. (2012). The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates. (ekstern lenke)
• Torunn Oveland Apelseth; Tor Hervig; Tore Wentzel-Larsen et al. (2011). A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. (ekstern lenke)
• Therese Bredholt; Elisabeth Ersvær; Bjarte Skoe Erikstein et al. (2013). Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine. (ekstern lenke)
• Håkon Reikvam; Astrid Marta Olsnes Kittang; Guro Kristin Melve et al. (2013). Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?. (ekstern lenke)
• Elise Aasebø; Annette Brenner; Maria Hernandez-Valladares et al. (2021). Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Elisabeth Ersvær et al. (2012). Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status - consequences and potentials for pharmacological intervention. (ekstern lenke)
• Frode Selheim; Elise Aasebø; Håkon Reikvam et al. (2024). Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations. (ekstern lenke)
• Miriam Sandnes; Øystein Sefland; Irini Ktoridou-Valen et al. (2025). RUNX1::MECOM rearrangement in myeloid neoplasm post cytotoxic therapy following sarcoma treatment: a case presentation and review of the literature. (ekstern lenke)
• Øyvind Bruserud; Eirik Bratland; Alexander Hellesen et al. (2017). Altered immune activation and IL-23 signaling in response to Candida albicans in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Thomas Knoop; Kristin Kampevold Larsen; Leh Friedemann et al. (2019). Severe Nephritis as Initial Sign of Waldenström's Macroglobulinemia. (ekstern lenke)
• Øyvind Bruserud; Bent Are Hansen; Nils Vetti et al. (2018). Successful eradication of leptomeningeal plasma cell disease. (ekstern lenke)
• Knut Anders Mosevoll; Bent-Are Hansen; Ingunn Margareetta Gundersen et al. (2022). Patients with Bacterial Sepsis Are Heterogeneous with Regard to Their Systemic Lipidomic Profiles. (ekstern lenke)
• Hanne Kristin Fredly; Håkon Reikvam; Bjørn Tore Gjertsen et al. (2012). Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment. (ekstern lenke)
• Ina Nepstad; Håkon Reikvam; Annette Brenner et al. (2018). Resistance to the antiproliferative in vitro effect of PI3K-Akt-mTOR inhibition in primary human acute myeloid leukemia cells is associated with altered cell metabolism. (ekstern lenke)
• Tor Henrik Anderson Tvedt; Kristin Paulsen Rye; Håkon Reikvam et al. (2015). The importance of sample collection when using single cytokine levels and systemic cytokine profiles as biomarkers - a comparative study of serum versus plasma samples. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Øystein Bruserud (2016). The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation. (ekstern lenke)
• Andreas Ingebrigtsen; Sahrai Saeed; Terje Hjalmar Larsen et al. (2024). Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study. (ekstern lenke)
• Håkon Reikvam; Geir Hetland; Farshid Ezligini et al. (2023). Safety of hypoxic red blood cell administration in patients with transfusion-dependent hematological malignancies: An interim analysis. (ekstern lenke)
• Annette Brenner; Tor Henrik Anderson Tvedt; Ina Nepstad et al. (2017). Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism. (ekstern lenke)
• Sushma Bartaula-Brevik; Calum Leitch; Maria del Carmen Hernandez Valladares et al. (2023). Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. (ekstern lenke)
• Maria Hernandez-Valladares; Rebecca Wangen; Elise Aasebø et al. (2021). Proteomic studies of primary acute myeloid leukemia cells derived from patients before and during disease-stabilizing treatment based on all-trans retinoic acid and valproic acid. (ekstern lenke)
• Ina Nepstad; Håkon Reikvam; Geir Strandenes et al. (2014). Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation. (ekstern lenke)
• Sofie Strand Klausen; Tor Hervig; Jerard Seghatchian et al. (2014). Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients. (ekstern lenke)

Fagartikkel

• Hilde K. Gjelberg; Lars Helgeland; Knut Liseth et al. (2023). Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature. (ekstern lenke)
• Marte Karen Brattås; Helge Kollsete Gjelberg; Vernesa Dizdar et al. (2019). En kvinne i 40-?rene med bekkensmerter og uklare MR-funn. (ekstern lenke)
• Håkon Reikvam; Jakob Dalgaard; Silje Johansen et al. (2019). Behandling av akutt myelogen leukemi hos eldre. (ekstern lenke)
• Nasir Saeed; ERLEND MOEN TAULE; Nils Vetti et al. (2024). En kvinne i 30-årene med dyspné to uker etter bukplastikkoperasjon. (ekstern lenke)
• Håkon Reikvam; Øystein Alexander Power; Pål Høvding et al. (2012). En mann med smerter etter kneoperasjon. (ekstern lenke)
• Håkon Reikvam; Rune Fanebust; Hilde Gjelberg et al. (2017). Ei ung kvinne med brystsmerter og dyspne. (ekstern lenke)
• Anh Khoi Vo; Håkon Reikvam; Helga Bergljot Midtbø et al. (2020). Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy. (ekstern lenke)

Leserbrev

• Ingvild Hausberg Sørvoll; Ingvild Jenssen Lægreid; Tom Sollid et al. (2024). Low Incidence of Anti-PF4/Heparin Antibodies in Patients with Acute Myelogenous Leukemia. (ekstern lenke)
• Galina Tsykunova; Håkon Reikvam; Randi Hovland et al. (2012). The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status. (ekstern lenke)
• Sverre Holm; Annika Elisabet Michelsen; Nina Haagenrud Schultz et al. (2024). Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses – a case report. (ekstern lenke)
• Adam J. Kanack; Ingvild Jenssen Lægreid; Silje Johansen et al. (2022). Human papilloma virus vaccine and VITT antibody induction. (ekstern lenke)

Lederartikkel

• Anh Khoi Vo; Tor Audun Hervig; Håkon Reikvam (2022). Pure red cell aplasia after hematopoietic stem cell transplantation - experimental therapeutic approaches. (ekstern lenke)
• Daniel Limi Cacic; Håkon Reikvam (2023). Liposomal drug formulations for treatment of hematological malignancies. (ekstern lenke)
• Håkon Reikvam; Richard Dillon (2024). Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia. (ekstern lenke)
• Linn Åsholt Rolsdorph; Knut Anders Mosevoll; Håkon Reikvam (2022). Cytomegalovirus induced hemophagocytic lymphohistiocytosis: diagnostic and treatment challenges for the future. (ekstern lenke)
• Solveig Simmenes Fotland; Håkon Reikvam; Tor Hervig et al. (2009). Does the preoperative iron status predict transfusion requirement of orthopedic patients?. (ekstern lenke)
• Guro Kristin Melve; Miriam Sandnes; Håkon Reikvam (2022). Autologous hematopoietic stem cell grafts - moving away from a one-size-fits-all approach. (ekstern lenke)
• Håkon Reikvam; Ina Nepstad; Jerome Tamburini (2013). Predicting effects of kinase inhibitor in therapy for myeloid malignancies - the challenges in capturing disease heterogeneity. (ekstern lenke)
• Øystein Bruserud; Håkon Reikvam (2010). Therapeutic targeting of NF-kappa B in myelodysplastic syndromes and acute myeloid leukaemia - the biological heterogeneity. (ekstern lenke)
• Håkon Reikvam; Anette Lodvir Hemsing; Catherine Smith (2020). Therapy for acute myelogenous leukemia revisited: moving away from a one-size-fits-all approach. (ekstern lenke)
• Håkon Reikvam; Tor Audun Hervig (2025). Hypoxic storage of red blood cells to improve transfusion outcomes in hematological malignancies. (ekstern lenke)
• Hilde Gjelberg; Lars Helgeland; Galina Tsykunova et al. (2024). Bone marrow aspirate or biopsy for multiple myeloma: when percentages matter!. (ekstern lenke)
• Håkon Reikvam; Silje Johansen; Christian Koenecke (2021). Future perspective: precision medicine to improve treatment results in the settings of allogenic stem cell transplantation for acute myelogenous leukemia. (ekstern lenke)
• Øystein Bruserud; Håkon Reikvam (2010). Heat shock protein 90 (HSP90) inhibition-From experimental to clinical studies. (ekstern lenke)
• Øystein Bruserud; Kimberley Joanne Hatfield; Håkon Reikvam (2011). Heat shock protein 90 (HSP90) inhibition in acute myeloid leukemia-Targeting of disease heterogeneity through direct and indirect antileukemic effects. (ekstern lenke)
• Håkon Reikvam; Anette Lodvir Hemsing; Maria Hernandez-Valladares et al. (2022). Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia. (ekstern lenke)
• Håkon Reikvam (2023). Betre og tryggare allogen stamcelletransplantasjon. (ekstern lenke)

Doktorgradsavhandling

• Knut Anders Mosevoll; Håkon Reikvam; Øystein Bruserud et al. (2017). Cytokine profiles in inflammation. (ekstern lenke)
• Håkon Reikvam (2012). New therapeutic targets in human acute myeloid leukemia. (ekstern lenke)

Konferanseabstrakt

• Håkon Reikvam; Kimberley Joanne Hatfield; Astrid Marta Olsnes et al. (2009). PRIMARY HUMAN ACUTE MYELOGENOUS LEUKEMIA CELLS SHOW CONSTITUTIVE RELEASE OF SEVERAL MATRIX METALLOPROTEASES AND THEIR INHIBITORS. (ekstern lenke)
• Håkon Reikvam; Egil Steien; Bjarne Hauge et al. (2009). TREATMENT OF ORBISAC DERIVED BUFFY COAT PLATELETS WITH THE MIRASOL (R) PATHOGEN REDUCTION TECHNOLOGY AND STORAGE IN ADDITIVE SOLUTION. (ekstern lenke)
• Håkon Reikvam; Guro Kristin Melve; Kjersti Svendheim et al. (2010). Why is potentional blood donors deferred from donation?. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Elisabeth Ersvær et al. (2010). PHARMACOLOGICAL TARGETING OF THE PI3K-AKT/PKB-MTOR PATHWAY ALTERS LOCAL ANGIOREGULATION IN ACUTE MYELOGENOUS LEUKEMIA. (ekstern lenke)

Populærvitenskapelig artikkel

• Tor Hervig; Tor Henrik AnderSon Tvedt; Thomas Knoop et al. (2021). En ung kvinne med pustevansker og proteinuri. (ekstern lenke)

Medieintervju

• Eline B. Rognli; Marianne Riksheim Stavseth; Ingunn Margareetta Gundersen et al. (2025). Pris til studie om tvungent psykisk helsevern og tidligere kriminalitet. (ekstern lenke)

Konferanseposter

• Seyed Mohammad Lellahi; Waqas Azeem; Yaping Hua et al. (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function. (ekstern lenke)
• Gülen Arslan Lied; Jian Chen; Håkon Reikvam (2014). The Role of Research Supervision on Doctoral Degree. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin